Description: 3-epi-Resibufogenin (compound 2) is an anticancer agent obtained through the biotransformation of Resibufogenin by Actinomucor elegans AS 3.2778. It demonstrates cytotoxicity against cancer cells, with IC50 values of 42.5 μM (A549) and 48.4 μM (H1299).